Dr. Mario Rocci Joins The IMA Group as Strategic Advisor in Clinical Research
Dr. Mario Rocci Joins The IMA Group as Strategic Advisor in Clinical Research Share Article The IMA Group announced today that industry veteran Dr. Mario Rocci has joined the company's Clinical Research division as its new Strategic Advisor. Dr. Rocci will help expand the company's office-based, decentralized and virtual clinical trials. TARRYTOWN, N.Y. (PRWEB) January 12, 2021 Mario Rocci, PhD, FCP, FFIP, a seasoned executive with 35 years of scientific and business management experience, has joined The IMA Group (IMA) as Strat...
Source: prweb.com